Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.
Lancet Reg Health Eur
; 13: 100275, 2022 Feb.
Article
em En
| MEDLINE
| ID: mdl-34901915
AIT, allergy immunotherapy; AR, allergic rhinitis; Allergic rhinitis; Allergy; Allergy immunotherapy; Asthma; Effectiveness; FU, follow-up; HDM, house dust mite; HRU, health care resource utilisation; ICS, inhaled corticosteroids; INCS, intranasal corticosteroids; LABA, long-acting beta2-agonists; PSM, propensity score matching; RCT, randomised clinical trial; RWE, real world evidence; Real-world evidence; Retrospective cohort study; Rx, prescription; SABA, short-acting beta2-agonists; SCIT, subcutaneous immunotherapy; SLIT, sublingual immunotherapy
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article